To the full analysis
Illumina stock: growth
ILMNIllumina reported $4.34B in revenue for fiscal 2025, down 0.8% on the prior year, up 6% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
18.1%
per year from 2006 to 2025, per share 14.7%
Earnings (Annual rate)
17.5%
per year from 2006 to 2025, per share 14.1%
Free cash flow (Annual rate)
21.3%
per year from 2006 to 2025, per share 17.8%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 6.0% | 6.9% | 18.1% |
| Revenue per share | 4.9% | 6.2% | 14.7% |
| Earnings | 5.3% | 6.3% | 17.5% |
| Earnings per share | 4.2% | 5.6% | 14.1% |
| Free cash flow | 0.9% | 6.1% | 21.3% |
| Free cash flow per share | −0.2% | 5.4% | 17.8% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $184.59M | $39.97M | $23.79M |
| 2007 | $366.8M | −$278.36M | $31.87M |
| 2008 | $573.23M | $50.48M | −$7.81M |
| 2009 | $666.32M | $72.28M | $119.27M |
| 2010 | $902.74M | $124.89M | $216.11M |
| 2011 | $1.06B | $86.63M | $278.59M |
| 2012 | $1.15B | $151.25M | $210.86M |
| 2013 | $1.42B | $125.31M | $295.86M |
| 2014 | $1.86B | $353.35M | $359.06M |
| 2015 | $2.22B | $461.56M | $516.35M |
| 2016 | $2.4B | $462.65M | $415.86M |
| 2017 | $2.75B | $726M | $563M |
| 2018 | $3.33B | $826M | $846M |
| 2019 | $3.54B | $1B | $842M |
| 2020 | $3.24B | $656M | $891M |
| 2021 | $4.53B | $762M | $337M |
| 2022 | $4.58B | −$4.4B | $106M |
| 2023 | $4.5B | −$1.16B | $282M |
| 2024 | $4.37B | −$1.22B | $709M |
| 2025 | $4.34B | $850M | $931M |
Revenue by segment
How Illumina, Inc. makes its money and how that has shifted. Names are as the company reports them.
- Sequencing$4.0B92%
- Microarray$358.0M8%
The company split earlier years differently. A history would not be comparable, so only 2025 is shown.
Figures as a table
| 2025 | Share 2025 | |
|---|---|---|
| Sequencing | $3.99B | 91.9% |
| Microarray | $358M | 8.3% |
| Total revenue | $4.34B | 100% |
Revenue by region
Where Illumina, Inc. generates its revenue.
- Americas55%
- EMEA29%
- Asia Pacific10%
- China6%
Figures as a table
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share 2025 | |
|---|---|---|---|---|---|---|---|---|
| Americas | $1.97B | $1.74B | $2.36B | $2.48B | $2.52B | $2.44B | $2.41B | 55.5% |
| EMEA | $933M | $886M | $1.29B | $1.22B | $1.14B | $1.19B | $1.26B | 29.1% |
| Asia Pacific | $268M | $267M | $377M | $418M | $459M | $438M | $430M | 9.9% |
| China | $372M | $342M | $502M | $472M | $384M | $308M | $243M | 5.6% |
| Total revenue | $3.54B | $3.24B | $4.53B | $4.58B | $4.5B | $4.37B | $4.34B | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 28 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 27 Oct 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.